top of page
A Longevity Biotechnology Company
Extended Longevity
IRB 2021-2023.
The Longevinaut Study #1
​
THE SAFETY AND EFFECTIVENESS OF THE EXTENDED LONGEVITY
PROTOCOL ON THE EPIGENETIC AGING RATE IN HEALTHY INDIVIDUALS
Protocol Number: TD-EL-001
IRB approval number: IRCM-2019-285
Click here for Study
Conducted by
Quantum Functional Medicine of Carlsbad, California
Dr. Juergen Winkler, MD
Through the Institute of Regenerative and Cellular Medicine (IRCM) of Santa Monica,
California, Executive Director Dr. Barbara Krutchkoff, PhD
bottom of page